Form 4: Guardant Health CMO's Routine Stock Vesting and Tax Sale

Guardant Health's Chief Medical Officer, Craig Eagle, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Summary

• Craig Eagle, Chief Medical Officer of Guardant Health, Inc. (GH), reported transactions on December 15, 2025.
• Acquired 1,402 shares of common stock through the vesting of restricted stock units at a price of $0.
• Disposed of 711 shares of common stock at a price of $102.67 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Eagle directly beneficially owns 45,007 shares of common stock.
• An additional 2,804 restricted stock units remain beneficially owned.
• The RSU award was granted on June 9, 2023, with 33% vesting on June 15, 2024, and the remainder vesting in equal quarterly installments over two years.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-scheduled executive compensation event (vesting of RSUs and subsequent tax-related sale). It is neutral in terms of company performance or strategic direction, reflecting standard corporate governance and compensation practices.

Positives

• The vesting of restricted stock units indicates continued compensation and retention of a key executive.
• The transaction is a routine part of executive compensation, reflecting a planned vesting schedule.

Negatives

• A portion of shares (711) was sold, reducing the direct beneficial ownership, although this was for tax purposes.

Future Outlook

The filing details a pre-scheduled vesting of restricted stock units, with remaining units set to vest in equal quarterly installments over the next two years, indicating a predictable future compensation structure for the executive.

Management Comments

• These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
• This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Industry Context

This transaction is a standard occurrence in the biotechnology and healthcare industry, where executive compensation often includes equity awards like restricted stock units that vest over time. Such filings provide transparency into executive stock ownership and compensation practices, which are common across publicly traded companies.

Comparison to Industry Standards

• NA

Related Party Transactions

• The disposition of 711 shares to the company for tax withholding purposes in connection with RSU vesting is a related party transaction, as it involves the company and an executive.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and ownership, confirming a key executive's continued equity stake, albeit with a minor reduction due to tax sales.
• Employees: Reflects standard executive compensation practices, which can influence broader compensation strategies.

Next Steps

• Remaining 2,804 restricted stock units will vest in equal quarterly installments over the next two years.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled vesting of restricted stock units and a subsequent sale of shares to cover tax obligations by a Chief Medical Officer. Such transactions are common and do not typically indicate a change in the company's fundamental outlook or performance. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is appropriate as this is a neutral event.

Keywords

Guardant Health, GH, Craig Eagle, Chief Medical Officer, Form 4, SEC filing, stock vesting, restricted stock units, RSU, insider transaction, tax withholding, beneficial ownership